Beviguen
1
9M
1
- Stages of investment
- Areas of investment
Summary
The venture was found in Europe in France. The main office of represented VC is situated in the Paris.
The standard case for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Sanofi-Genzyme BioVentures, Quest for Growth, Auriga Partners.
Among the most popular portfolio startups of the fund, we may highlight NGI. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - France. Among the most popular fund investment industries, there are Web Development, Advertising.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2007.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Investments by industry
- Bioinformatics (1)
- Biotechnology (1)
- Advertising (1)
- Web Development (1)
- Investments by region
-
- France (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| NGI | 19 Dec 2007 | Biotechnology, Advertising, Web Development, Bioinformatics | Early Stage Venture | 9M | Pays de la Loire, Nantes, France |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.